Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 138

    Merck Q1 net profit up as cancer drug, vaccine sales soar

    Merck Q1 net profit up as cancer drug, vaccine sales soar

    Garima3 May 2019 9:00 AM IST
    Gardasil, a vaccine for preventing cancers associated with human papillomavirus, powered much of the earnings beat, helped by higher vaccination rates...
    Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution

    Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution

    Farhat Nasim2 May 2019 4:04 PM IST
    Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% is indicated for the treatment of ocular itching associated with allergic conjunctivitis.New...
    Sanofi wins USFDA approval to sell dengue vaccine Dengvaxia in parts of US

    Sanofi wins USFDA approval to sell dengue vaccine Dengvaxia in parts of US

    Farhat Nasim2 May 2019 10:00 AM IST
    Dengvaxia is a live, attenuated vaccine that is administered as three separate injections, with the initial dose followed by two additional shots...
    AstraZeneca ties up with Transgene to develop viral immunotherapies

    AstraZeneca ties up with Transgene to develop viral immunotherapies

    Garima2 May 2019 9:25 AM IST
    AstraZeneca has been moving deeper into cancer therapy market through wide-ranging deals, including those for immunotherapy and targeted therapy.New...
    Novartis division strikes deal with Eir Genix to market biosimilar of Herceptin

    Novartis division strikes deal with Eir Genix to market biosimilar of Herceptin

    Medical Dialogues Bureau2 May 2019 9:15 AM IST
    EirGenix will be responsible for development and manufacturing, while Sandoz has the right to commercialize in all markets except China and Taiwan....
    Pfizer Q1 profit up 9 percent on higher drug sales, lower costs

    Pfizer Q1 profit up 9 percent on higher drug sales, lower costs

    Medical Dialogues Bureau2 May 2019 9:07 AM IST
    Pfizer modestly lifted its full-year profit forecast. The company also bought back $8.9 billion worth of shares in the first quarter, a jump from the...
    GSK expects shingles drug sales to exceed $1.3 billion

    GSK expects shingles drug sales to exceed $1.3 billion

    Garima2 May 2019 9:00 AM IST
    FTSE-100 member GSK, whose shares were up 0.3 per cent to 1,580 pence at 1156 GMT, also said it had decided to stop the clinical development of its...
    Zydus Cadila gets USFDA nod to market 2 generic drugs

    Zydus Cadila gets USFDA nod to market 2 generic drugs

    Medical Dialogues Bureau1 May 2019 8:05 PM IST
    New Delhi: Drug firm Zydus Cadila Tuesday said it has received the final nod from the USFDA to market generic Bosentan tablets and Trientine...
    Lupin-Natco get USFDA nod to market generic hypertension drug

    Lupin-Natco get USFDA nod to market generic hypertension drug

    Medical Dialogues Bureau1 May 2019 8:05 PM IST
    New Delhi: Drug firm Lupin, in alliance with Natco Pharma, has received approval from the US health regulator to market generic Bosentan tablets used...
    Vaccine and blood thinner help drive Pfizer to quarterly earnings beat

    Vaccine and blood thinner help drive Pfizer to quarterly earnings beat

    Medical Dialogues Bureau1 May 2019 12:07 PM IST
    Pfizer Inc on Tuesday reported a first-quarter profit that beat Wall Street estimates and slightly raised its 2019 earnings forecast, as the company...
    USFDA declines to approve Nabriva

    USFDA declines to approve Nabriva's antibiotic Contepo for urinary tract infections

    Medical Dialogues Bureau1 May 2019 12:02 PM IST
    The U.S. Food and Drug Administration on Tuesday declined to approve Nabriva Therapeutics Plc's antibiotic Contepo for complicated urinary tract...
    Ghana becomes second country to launch vital malaria vaccine

    Ghana becomes second country to launch vital malaria vaccine

    Medical Dialogues Bureau1 May 2019 10:04 AM IST
    Ghana on Tuesday rolled out the world's only proven malaria vaccine for infants as part of a landmark campaign against the deadly mosquito-borne...
    PrevNext

    Popular Stories

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Protect Your Loved Ones with a Term Plan that’s Smart

    Protect Your Loved Ones with a Term Plan that’s Smart

    Unichem Labs net loss narrows to Rs 22 crore in September quarter

    Unichem Labs net loss narrows to Rs 22 crore in September quarter

    Strides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MD

    Strides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MD

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok